Genomic Valley Biotech Ltd
BSE: 539206
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 0.04-25.0% | 0.05-44.4% | 0.09+0.0% | 0.09-65.8% | 0.26+19.8% | 0.22+10.0% | 0.20 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | — | 0.01 |
| Total Income | 0.04-25.0% | 0.05-44.4% | 0.09+0.0% | 0.09-65.9% | 0.26+19.3% | 0.22+5.2% | 0.21 |
| EXPENSES | |||||||
| Expenditure | 0.04-9.1% | 0.04-54.4% | 0.09+32.8% | 0.07-75.0% | 0.26+302.6% | 0.07-7.1% | 0.07 |
| Tax | 0.01 | 0.00 | 0.00 | 0.00-100.0% | 0.09 | — | — |
| PROFIT | |||||||
| PBT | 0.00-84.8% | 0.01+218.2% | 0.00-86.6% | 0.02+1200.0% | 0.00-98.8% | 0.15+3.3% | 0.15 |
| Net Profit | -0.01-177.1% | 0.01+218.2% | 0.00-86.6% | 0.02+129.6% | -0.08-153.8% | 0.15+3.3% | 0.15 |
| KEY METRICS | |||||||
| OPM % | 7.73%-14.87pp | 22.60%+18.04pp | 4.56%-23.77pp | 28.33%+27.27pp | 1.06% | — | 75.00% |
| NPM % | -21.60%-42.60pp | 21.00%+17.33pp | 3.67%-23.77pp | 27.44%+59.08pp | -31.64%-101.78pp | 70.14%-4.86pp | 75.00% |
| EPS | 0.03+0.0% | 0.03+200.0% | 0.01-87.5% | 0.08-70.4% | 0.27-47.1% | 0.51+920.0% | 0.05 |
Corporate Events
Board MeetingGVBL
202629May
Board Meeting
To consider and approve the audited financial results (stand…
BSE Filing ↗ Board MeetingGVBL
202615Jan
Board Meeting
Considered and approved the standalone Un-audited financial …
BSE Filing ↗ Board MeetingGVBL
20247Oct
Board Meeting
consider and approve the unaudited financial results (standa…
BSE Filing ↗ Board MeetingGVBL
202429Jul
Board Meeting
considering and approving the unaudited financial results (s…
BSE Filing ↗ Board MeetingGVBL
20249May
Board Meeting
consider and approve audited financial results, quarter and …
BSE Filing ↗